Back to recall look-up

Recall archive

95,439 stored notices, from Jun 20, 2012 to Nov 11, 2026.

163 recalls · page 5 of 7

Drugs

Reported Mar 15, 2017

Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Teva Pharmaceuticals USA

Matched: Brand · Product details — Failed Dissolution Specifications: low out of specification dissolution results found during stability testing.

FDA (openFDA drug enforcement)

Drugs

Reported Feb 22, 2017

Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva Pharmaceuticals USA

Matched: Brand · Product details — Failed Impurities/Degradation Specifications: out of specification test results for the norethindrone impurity.

FDA (openFDA drug enforcement)

Drugs

Reported Feb 1, 2017

Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva Pharmaceuticals USA

Matched: Brand · Product · Product details — Subpotency: due to a low, out of specification test result for assay during stability testing.

FDA (openFDA drug enforcement)

Drugs

Reported Jan 25, 2017

Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Teva Pharmaceuticals USA

Matched: Brand · Product details — Failed Dissolution Specifications

FDA (openFDA drug enforcement)

Drugs

Reported Dec 14, 2016

Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Teva Pharmaceuticals USA

Matched: Brand · Product · Product details — Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 26, 2016

PARICALCITOL Capsules, 1 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Teva Pharmaceuticals USA

Matched: Brand · Product · Product details — Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.

2 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 19, 2016

Amikacin Sulfate Injection, USP, 500 mg/2 mL (250 mg/mL) Rx Only, Manufactured in Hungary For: Teva Pharmaceuticals…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva Pharmaceuticals USA

Matched: Brand · Product · Product details — CGMP Deviations

2 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Oct 12, 2016

Claravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules Each (30…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Teva North America

Matched: Brand · Product details — Failed Impurities/Degradation Specifications.

FDA (openFDA drug enforcement)

Drugs

Reported Sep 14, 2016

ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva North America

Matched: Brand · Product · Product details — CGMP Deviations

3 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Aug 17, 2016

Albuterol Sulfate Syrup, 2 mg/ 5 mL, 473 mL bottle, Rx only, Manufactured in Canada by Contract Pharmaceuticals…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva North America

Matched: Brand · Product · Product details — Presence of Foreign Substance; presence of black particles describes generically as cellulose-based bundles of brown fibrous material.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 3, 2016

Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Teva North America

Matched: Brand · Product · Product details — Failed Tablet/Capsule Specifications

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Jun 1, 2016

Linezolid Injection, 600 mg/300 mL Single use container bags (NDC 0703-9060-31), packaged in 10 x 300 mL Single Use…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva North America

Matched: Brand · Product details — Lack of Assurance of Sterility: Due to potential for leaking bags.

FDA (openFDA drug enforcement)

Drugs

Reported Jun 1, 2016

Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manufactured in Hungary For: Teva…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Teva Pharmaceuticals USA

Matched: Brand · Product · Product details — Presence of Particulate Matter: particulate matter identified as glass in one vial.

FDA (openFDA drug enforcement)

Drugs

Reported May 11, 2016

Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC 636290-3324-2), b) 100-count bottle…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Bryant Ranch Prepack Inc.

Matched: Product details · Reason for recall — Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as…

FDA (openFDA drug enforcement)

Drugs

Reported Mar 23, 2016

NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Teva Pharmaceuticals USA

Matched: Brand · Product · Product details — Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Mar 9, 2016

Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by:…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva North America

Matched: Brand · Product details — Failed Dissolution Specifications: low test results at the 18 month time-point

FDA (openFDA drug enforcement)

Drugs

Reported Jan 20, 2016

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva Pharmaceuticals USA

Matched: Brand · Product details — Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.

FDA (openFDA drug enforcement)

Drugs

Reported Sep 23, 2015

ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only,…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

EMD Serono, Inc.

Matched: Product details — Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.

FDA (openFDA drug enforcement)

Drugs

Reported Sep 2, 2015

ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Teva Pharmaceuticals USA

Matched: Brand · Product details — Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution

FDA (openFDA drug enforcement)

Drugs

Reported Aug 12, 2015

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, (CII),…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva Pharmaceuticals USA

Matched: Brand · Product details — Failed Impurities/Degradation Specifications: out of specification for unknown impurity

FDA (openFDA drug enforcement)

Drugs

Reported Jul 15, 2015

Adrucil (fluorouracil injection, USP) Pharmacy Bulk Package Not for Direct Infusion, 5 g/100 mL (50 mg/mL), For…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Teva Pharmaceuticals USA

Matched: Brand · Product details — Presence of Particulate Matter: Black particulate matter was identified as aggregate of silicone rubber pieces from a filler diaphragm and…

FDA (openFDA drug enforcement)

Drugs

Reported Jun 17, 2015

Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only. Manufactured for: Teva Pharmaceuticals…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Valeant Pharmaceuticals North America LLC

Matched: Brand · Product · Product details — Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.

FDA (openFDA drug enforcement)

Drugs

Reported Jun 10, 2015

Zebeta¿ (bisoprolol fumarate), tablets, 10mg, 30-count bottle, Rx only, Manufactured for Teva Pharmaceuticals Inc. 425…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva Pharmaceuticals USA

Matched: Brand · Product · Product details — Failed Dissolution Specifications: OOS result during stability testing

FDA (openFDA drug enforcement)

Drugs

Reported Jun 3, 2015

QVAR (beclomethasone dipropionate HFA 40 mcg), 40 mcg Inhalation Aerosol, For Oral Inhalation with QVAR Actuator Only,…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Teva Pharmaceuticals USA

Matched: Brand · Product details — Failed Impurities/Degradation Specifications: out of specification test results for an impurity during stability testing.

FDA (openFDA drug enforcement)

RecallNow is not a government agency. Every notice above is published by the FDA, USDA FSIS, or CPSC and links back to its source. Back to the look-up